Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Teva
Cipla
Julphar
Harvard Business School
McKesson
Chinese Patent Office
Argus Health
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,948,807

« Back to Dashboard

Summary for Patent: 4,948,807
Title: Phenyl carbamates
Abstract:Phenyl carbamates of the general formula ##STR1## wherein R.sub.1 to R.sub.5 are as defined in the claims, are useful as pharmaceuticals.
Inventor(s): Rosin; Marta W. (Jerusalem, IL), Chorev; Michael (Jerusalem, IL), Tashma; Zeev (Jerusalem, IL)
Assignee: Proterra AG (Zug, CH)
Application Number:07/320,700
Patent Claims: 1. N-cyclohexyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof.

2. N-allyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof.

3. N-ethyl, N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate and pharmacologically acceptable salts thereof.

4. A method of treating a subject suffering from senile dementia, Alzhemier's disease, Huntingdon's chorea, tardive dyskinesias,, hyperkinesia, mania, acute confusion disorders, Friedrich's ataxia and Down's syndrome, which comprises administering to such a subject a therapeutically effective amount of a compound selected from the group consisting of N-cyclohexyl-3-[1-(dimethylamino)ethyl]phenyl carbamate, N-allyl-3-[1-(dimethylamino)ethyl]phenyl carbamate, N-ethyl, N-methyl-3[1-(dimethylamino)ethyl]phenyl carbamate, and pharmacologically acceptable salts thereof.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Baxter
Queensland Health
McKesson
Farmers Insurance
Express Scripts
Cantor Fitzgerald
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot